Is banning direct to consumer advertising of prescription medicine justified paternalism?

Journal of Bioethical Inquiry 2 (2):69-74 (2005)

New Zealand is one of two OECD countries in the world where direct-to-consumer advertising of prescription medicine (DTCA-PM) is permitted. Increase in such activity in recent years has resulted in a disproportionate increase in dispensary volume of heavily advertised medicines. Concern for the potential harm to healthcare consumers and the public healthcare system has prompted the medical profession to call for a ban on DTCA-PM as the best way of protecting the public interest. Such blanket prohibition however also interferes with the public’s right of access to information. This paper will examine if banning DTCA-PM would constitute a justified form of paternalism in the context of today’s New Zealand.
Keywords Drug industry  advertising  public policy  ethics
Categories (categorize this paper)
Reprint years 2006
DOI 10.1007/BF02448845
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

Our Archive

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 46,461
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Add more references

Citations of this work BETA

Add more citations

Similar books and articles

What’s Wrong with "Deceptive" Advertising?Daniel Attas - 1999 - Journal of Business Ethics 21 (1):49-59.


Added to PP index

Total views
76 ( #115,429 of 2,286,454 )

Recent downloads (6 months)
3 ( #419,675 of 2,286,454 )

How can I increase my downloads?


My notes

Sign in to use this feature